Back

ing. S.T. (Joost) Verhoeff

ing. S.T. (Joost) Verhoeff

Associate Professor - medical

Show full profile

Research Output (116)

Long term disease control and abscopal effects by stereotactic radiotherapy for growing metastases during anti-PD1

Suijkerbuijk K P, El Sharouni S Y, Damen P P, Lindert A V, Groenewegen G, Verhoeff J J C Oct 2018, In: Annals of Oncology. 29 Suppl 8 , p. viii428

MR-Only Brain Radiation Therapy:Dosimetric Evaluation of Synthetic CTs Generated by a Dilated Convolutional Neural Network

Dinkla Anna M., Wolterink Jelmer M., Maspero Matteo, Savenije Mark H.F., Verhoeff Joost J.C., Seravalli Enrica, Išgum Ivana, Seevinck Peter R., van den Berg Cornelis A.T. 22 May 2018, In: International Journal of Radiation Oncology Biology Physics. 102 , p. 801-812 12 p.

Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

Jeene Paul M, de Vries Kim C, van Nes Johanna G H, Kwakman Johannes J M, Wester Gerda, Rozema Tom, Braam Pètra M, Zindler Jaap D, Koper Peter, Nuyttens Joost J, Vos-Westerman Hanneke A, Schmeets Ilona, Niël Charles G H J, Hutschemaekers Stefan, Van Der Linden Yvette M., Verhoeff Joost J C, Stalpers Lukas J A May 2018, In: Acta Oncologica. 57 , p. 637-643

OC-0293: Dosimetric evaluation of deep learning based synthetic-CT generation for MR-only brain radiotherapy

Dinkla A. M., Wolterink J. M., Maspero M., Savenije M. H. F., Verhoeff J. J. C., Isgum I., Seevinck P. R., Lagendijk J. J. W., Van den Berg C. A. T. Apr 2018, In: Radiotherapy & Oncology. 127 , p. S151-S151

Ischemic stroke after radiation therapy for pituitary adenomas:a systematic review

van Westrhenen A., Muskens I. S., Verhoeff J. J.C., Smith T. R.S., Broekman M. L.D. 1 Oct 2017, In: Journal of Neuro-Oncology. 135 , p. 1-11

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection:A systematic review and meta-analysis

Lamba Nayan, Muskens Ivo S, DiRisio Aislyn C, Meijer Louise, Briceno Vanessa, Edrees Heba, Aslam Bilal, Minhas Sadia, Verhoeff Joost J.C., Kleynen Catharina E. , Smith Timothy R, Mekary Rania A, Broekman Marike L. 24 Jun 2017, In: Radiation Oncology [E]. 12

In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150<sup>Glued</sup>

van Lith Sanne A M, Roodink Ilse, Verhoeff Joost J C, Mäkinen Petri I., Lappalainen Jari P., Ylä-Herttuala Seppo, Raats Jos, van Wijk Erwin, Roepman Ronald, Letteboer Stef J., Verrijp Kiek, Leenders William P J 2016, In: Oncotarget. 7 , p. 71594-71607 14 p.

A 43-year-old female with multifocal cerebral lesions

Nieuwenhuis Marieke B B, Van Der Salm Sandra M A, Verhoeff Joost J C, Van Der Kooi Anneke J., Slavujecvic-Letic Ivana, Pals Steven T., Vos Josephine M I 1 May 2015, In: Brain Pathology. 25 , p. 371-372 2 p.

Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastomamultiforme

Van Linde Myra E., Verhoeff Joost J C, Richel Dirk J., Van Furth Wouter R., Reijneveld Jaap C., Verheul Henk M W, Stalpers Lukas J A 12 Jan 2015, In: Oncologist. 20 , p. 107-108 2 p.

Causes of severe visual impairment and blindness in children in the Republic of Suriname

Heijthuijsen Astrid Anna Maria, Beunders Victoria Apollonia Annemarie, Jiawan Dinesh, de Mesquita-Voigt Anne-Marie Bueno, Pawiroredjo Jerrel, Mourits Maarten, Tanck Michael, Verhoeff Joost, Saeed Peerooz Jul 2013, In: British Journal of Ophthalmology. 97 , p. 812-5 4 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not